C
Core Biogenesis
Biotech & Life Sciences · Strasbourg, France · Founded 2020
Core Biogenesis produces pharma-grade recombinant proteins with its plant-based bioproduction platform. Our first products are growth factors used for Cell Therapy manufacturing and Cultivated meat… MoreLess
Developer of bioproduction technologies designed to use plants as biofactories to scale the production of high-value bioproducts. The company's ultra-scalable bioproduction as a service (UBaaS) platform accelerates mass production and isolates molecules to a specific plant compartment, making extraction faster, and more scalable and it also offers proprietary gene editing and plant biotechnology to produce GF(Growth Factors) molecules used in the clean meat and cell therapy industries, which regulate the growth, division, and survival of cells, enabling clients to increase yields while driving down costs. Keywords: Pharmaceuticals and Biotechnology, Bioproduction Facility, Biotech Company, Biotechnology Processing, Cytokines Synthesis, Growth Factoring Molecules, Protein Production, Recombinant Molecule Production, Recombinant Protein Bioproduction.
Talent graph
Core Biogenesis's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Core Biogenesis has talent and traffic
team presence
Market sentiment
What the market is saying about Core Biogenesis
An AI-synthesized read of the highest-engagement posts about Core Biogenesis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Core Biogenesis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.





